What is it about estimates that quantify the high cost of drug development that seems to get everybody so worked up?
It is now one of the many recurring subthemes in the debate over drug pricing. The pharmaceutical industry publicizes estimates...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?